Populationpharmacokinetic/pharmacodynamic modeling of a new recombinant human factor VIIA (LR769) to derive the dose to be studied in phase 3

  • J. Frieling
  • , J. Stevens
  • , J. Reijers
  • , M. Moerland
  • , J. Burggraaf
  • , K. van Leuven
  • , C. Kluft
  • , J-F Schved

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Pages (from-to)966-966
Number of pages1
JournalJournal of Thrombosis and Haemostasis
Volume13
Publication statusPublished - Jun-2015

Cite this